Cargando…
Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome
Tactical disruption of protein synthesis is an attractive therapeutic strategy, with the first-in-class eIF4A-targeting compound zotatifin in clinical evaluation for cancer and COVID-19. The full cellular impact and mechanisms of these potent molecules are undefined at a proteomic level. Here, we re...
Autores principales: | Ho, J.J. David, Cunningham, Tyler A., Manara, Paola, Coughlin, Caroline A., Arumov, Artavazd, Roberts, Evan R., Osteen, Ashanti, Kumar, Preet, Bilbao, Daniel, Krieger, Jonathan R., Lee, Stephen, Schatz, Jonathan H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s).
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558842/ https://www.ncbi.nlm.nih.gov/pubmed/34644561 http://dx.doi.org/10.1016/j.celrep.2021.109806 |
Ejemplares similares
-
MATRIX platform to analyze translation machinery remodeling in glioblastoma cells
por: Ho, J.J. David, et al.
Publicado: (2022) -
Translatomics: The Global View of Translation
por: Zhao, Jing, et al.
Publicado: (2019) -
Proteomics reveal extensive translatome reprogramming and biomarkers of rocaglate toxicity and resistance in cancer
por: Ho, J.J.D., et al.
Publicado: (2020) -
The diversity, plasticity, and adaptability of cap-dependent translation initiation and the associated machinery
por: Borden, Katherine L.B., et al.
Publicado: (2020) -
tRanslatome: an R/Bioconductor package to portray translational control
por: Tebaldi, Toma, et al.
Publicado: (2014)